Pharmafile Logo
Pharmafocus logo
Advanced Search

Access to new cancer drugs limited in Brazil and Mexico

April 13, 2012
Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets

Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …

News

Januvia gains renal impairment licence in UK

April 13, 2012
Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment

Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …

News

UCB launches ‘Parkinson’s Well-Being Map’

April 13, 2012
Medical Communications Parkinson's disease, UCB

UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …

News
Steve Yang

Innovating in China’s pharma market

April 12, 2012
Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets

The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …

Feature

ViiV Healthcare appoints Just:: Health PR

April 12, 2012
Medical Communications, Sales and Marketing HIV/AIDS, Just::, PR, ViiV

ViiV Healthcare has appointed Just:: Health PR to work on an integrated political and public relations initiative that will engage …

News
Roche

Roche on target despite European shrinkage

April 12, 2012
Sales and Marketing Illumina, Q1 2012, Roche

Roche saw its business grow in the first three months of the year, thanks to strong showings from hepatitis C …

News

EMA backs full access to trial data

April 12, 2012
Business Services, Research and Development, Sales and Marketing EMA, clinical trial data, data disclosure, regulatory affairs, transparency

The European Medicines Agency says it wants to open up access to full clinical trial data, but warns that some …

News

immatics appoints Dr Rainer Kramer as its new
 chief business officer

April 12, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

immatics biotechnologies, a biopharma company developing therapeutic cancer vaccines, has appointment Dr Rainer Kramer as its new chief business officer. …

Appointment

Algeta to co-promote Alpharadin in US

April 12, 2012
Sales and Marketing Algeta, Bayer, prostate cancer

Algeta has exercised its option to co-promote Alpharadin for the treatment of cancer patients with bone metastases in the United …

News

Humira gains European licence for ulcerative colitis

April 11, 2012
Sales and Marketing Humira, ulcerative colitis

Abbott’s Humira has gained European approval to treat ulcerative colitis, adding to its six existing licences.   It can now …

News

UK launches ‘biomedical catalyst’ fund

April 11, 2012
Biotechnology, SMEs, biomedical catalyst, strategy for life sciences

A £180 million government fund to help innovative small and medium sized enterprises (SMEs) and academics to develop solutions to …

News
Amgen

Amgen to acquire kidney disease specialist for $315m

April 11, 2012
Sales and Marketing Amgen, KAI Pharmaceuticals

Amgen will acquire KAI Pharmaceuticals for $315 million to bolster its late-stage pipeline. The deal, which should be completed within …

News
ICON HQ

A more ‘nimble approach’ needed for CRO-pharma partnerships

April 10, 2012
Research and Development CRO, partnerships

Pharma firms need to create closer and more flexible relationships with their contract research organisations for better outcomes. This is …

News

J&J unveils plans to boost Doxil supplies

April 10, 2012
Manufacturing and Production Ben Venue, Doxil, J&J, JJ, drug shortages

Johnson & Johnson is planning to transfer filling and packaging of Doxil to another supplier in an attempt to alleviate …

News

Investors ramp up pressure on AZ chief

April 10, 2012
Sales and Marketing AstraZeneca, David Brennan

AstraZeneca’s chief executive David Brennan is coming under increasing pressure from investors, and his future at the firm could be …

News

Codexis and Merck develop green Victrelis production

April 10, 2012
Manufacturing and Production Codexis, Merck, manufacturing

Merck has teamed up with catalyst specialist Codexis to develop a more efficient manufacturing process for recently-approved hepatitis C treatment …

News

Alzheimer’s diagnostic comes with caveats

April 10, 2012
Sales and Marketing Alzheimer's, Amyvid, lilly

A first-in-class test for Alzheimer’s disease has been approved by the FDA, but its makers have stressed its limitations.Lilly’s Amyvid …

News
Novo Nordisk HQ

Victoza superiority to Januvia made official by FDA

April 10, 2012
Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes

Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …

News

Sheri McCoy resigns from Johnson & Johnson

April 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson & Johnson, Sheri McCoy, resignation

Johnson & Johnson has announced that Sheri McCoy, vice chairman of the executive committee, will leave the company on April …

Appointment

Submission of labels and leaflets in the UK

April 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Labelling, Wainwright Associates

The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels and patient leaflets for medicinal …

News
Press release
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026